TY - JOUR
T1 - MGuard embolic protection stent - The importance of thrombus management in ST-elevation myocardial infarction primary percutaneous coronary intervention
AU - Costa, Ricardo
AU - Abizaid, Alexandre
AU - Fajadet, Jean
AU - Lotan, Chaim
AU - Kornowski, Ran
AU - Dudek, Dariusz
AU - Henriques, José P.S.
AU - Amoroso, Giovanni
AU - Mountfort, Katrina
PY - 2014
Y1 - 2014
N2 - Distal embolisation of atherothrombotic material is a frequent consequence of percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI). This causes microvascular occlusions, leading to a further reduction in myocardial reperfusion. The MGuard™ embolic protection stent (EPS) features a unique polymer micronet mesh coating. When used in acute STEMI, the MGuard EPS shows significant improvement in myocardial flow and ST resolution, even in complicated clinical cases vs the standard approach with conventional bare metal or drug-eluting stents. Data from the andomised Safety and Efficacy Study of MGuard Stent After a Heart Attack (MASTER II) trial and from a real-life registry have shown the efficacy and safety of the MGuard in primary PCI. This report of the proceedings of a symposium at EuroPCR, 20-23 May 2014, Paris, France, discussed clinical trial data, as well as a number of clinical cases, illustrating the utility of the MGuard EPS in difficult situations.
AB - Distal embolisation of atherothrombotic material is a frequent consequence of percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI). This causes microvascular occlusions, leading to a further reduction in myocardial reperfusion. The MGuard™ embolic protection stent (EPS) features a unique polymer micronet mesh coating. When used in acute STEMI, the MGuard EPS shows significant improvement in myocardial flow and ST resolution, even in complicated clinical cases vs the standard approach with conventional bare metal or drug-eluting stents. Data from the andomised Safety and Efficacy Study of MGuard Stent After a Heart Attack (MASTER II) trial and from a real-life registry have shown the efficacy and safety of the MGuard in primary PCI. This report of the proceedings of a symposium at EuroPCR, 20-23 May 2014, Paris, France, discussed clinical trial data, as well as a number of clinical cases, illustrating the utility of the MGuard EPS in difficult situations.
KW - Acute myocardial infarction
KW - Distal embolisation
KW - Distal thromboembolism
KW - Mesh
KW - Percutaneous coronary intervention
KW - ST-elevation myocardial infarction
KW - STEMI
KW - Stent
KW - Target lesion
KW - Thrombus
KW - Thrombus loaded lesion
UR - http://www.scopus.com/inward/record.url?scp=84938281976&partnerID=8YFLogxK
U2 - 10.15420/icr.2014.9.3.168
DO - 10.15420/icr.2014.9.3.168
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84938281976
SN - 1756-1477
VL - 9
SP - 168
EP - 174
JO - Interventional Cardiology: Reviews, Research, Resources
JF - Interventional Cardiology: Reviews, Research, Resources
IS - 3
ER -
